U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948331) titled 'RADA16 for Aquablation Day Case' on April 21.
Brief Summary: This is a pilot proof of concept single-arm study using PuraStat following Aquablation procedure to assess reduction of hematuria to allow for same day discharge.
The primary objective is to assess how PuraStat affects post-operative hematuria following Aquablation.
The secondary objective is to assess the number of patients discharged on the same day based on the hematuria criteria (Grade 0 and Grade I).
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Hematuria
Benign Prostatic Hyperplasia
Lower Urinary Tract Symptoms
Intervention:
DEVICE: PuraStat...